These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 6789619)
1. Heat-inactivated Brucella suspensions as modulators of hosts' defence against tumour. (Short communication). Réthy L; Géresi M; Gelencsér F; Ecsy R; Padányi M; Pogány I; Bácskai L; Réthy LA Acta Vet Acad Sci Hung; 1981; 28(3):277-9. PubMed ID: 6789619 [No Abstract] [Full Text] [Related]
2. Immunomodulation of primary antitoxic-type immunity with inactivated Brucella suspensions. Réthy L; Réthy LA; Géresi M Acta Vet Hung; 1983; 31(1-3):43-9. PubMed ID: 6234766 [No Abstract] [Full Text] [Related]
3. Antitumour effect of different corynebacterial immunostimulants in non isogenic mouse-tumour-system. (Short communication). Géresi M; Réthy L; Ecsy R; Gelencsér F; Padányi M; Pogány I; Bácskai L; Réthy LA Acta Vet Acad Sci Hung; 1981; 28(3):281-3. PubMed ID: 7258017 [No Abstract] [Full Text] [Related]
4. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242 [TBL] [Abstract][Full Text] [Related]
5. [Increase in the immunostimulation properties of inactivated Brucella abortus B 19 by simultaneous use of a specific immune serum]. Toujas L; Dazord L; Guefi J C R Acad Hebd Seances Acad Sci D; 1973 Jan; 276(3):433-6. PubMed ID: 4197497 [No Abstract] [Full Text] [Related]
6. Effect of antibiotics on the development of immune response in the organism of animals. IV. Rabbit experiments with a Brucella vaccine (B19) and its heat-inactivated variant. Tran DT Acta Vet Acad Sci Hung; 1981; 29(2):127-41. PubMed ID: 6805267 [No Abstract] [Full Text] [Related]
7. Programming of CTL with heat-killed Brucella abortus and antigen allows soluble antigen alone to generate effective secondary CTL. Inoue S; Golding B; Scott D Vaccine; 2005 Feb; 23(14):1730-8. PubMed ID: 15705479 [TBL] [Abstract][Full Text] [Related]
8. Genetic (h-2) dependence of the duration of splenomegaly induced by Brucella abortus. Oth D; Sabolovic D; Le Garrec Y Folia Biol (Praha); 1974; 20(1):20-5. PubMed ID: 4215683 [No Abstract] [Full Text] [Related]
9. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155 [TBL] [Abstract][Full Text] [Related]
10. Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model. Lee IK; Olsen SC; Bolin CA Can J Vet Res; 2001 Oct; 65(4):223-8. PubMed ID: 11768128 [TBL] [Abstract][Full Text] [Related]
11. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039 [TBL] [Abstract][Full Text] [Related]
12. [Immunological responses of the Ehrlich tumor bearing mice of various stages (author's transl)]. Kato T Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):564-70. PubMed ID: 1243727 [No Abstract] [Full Text] [Related]
13. The adjuvant effect of a single dose of interleukin-12 on murine immune responses to live or killed Brucella abortus strain RB51. Lee IK; Olsen SC; Kehrli M; Bolin CA Can J Vet Res; 1999 Oct; 63(4):284-7. PubMed ID: 10534009 [TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798 [TBL] [Abstract][Full Text] [Related]
15. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis. Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756 [TBL] [Abstract][Full Text] [Related]
16. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle. Wyckoff JH; Howland JL; Scott CM; Smith RA; Confer AW Vet Microbiol; 2005 Nov; 111(1-2):77-87. PubMed ID: 16242273 [TBL] [Abstract][Full Text] [Related]
17. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. Zhan Y; Cheers C J Immunol; 1998 Aug; 161(3):1447-53. PubMed ID: 9686610 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554 [TBL] [Abstract][Full Text] [Related]
19. [Human pathogenic gram-negative microorganisms as stimulators of the body's antitumor resistance]. Zatula DG; Zaval'niuk AK; Mironiuk SI; Tofan AV Klin Khir (1962); 1986; (5):54-7. PubMed ID: 2874257 [No Abstract] [Full Text] [Related]
20. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs. Woodard LF; Toone NM; Jasman RL Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]